Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.47 USD | 0.00% | +10.76% | -37.31% |
Mar. 12 | Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering | CI |
Mar. 07 | Piper Sandler Adjusts Price Target on MDxHealth to $7 From $6, Maintains Overweight Rating | MT |
Sales 2023 | 64.39M 68.84M | Sales 2024 * | 73.53M 78.62M | Capitalization | 63.14M 67.51M |
---|---|---|---|---|---|
Net income 2023 | -39M -41.7M | Net income 2024 * | -26M -27.8M | EV / Sales 2023 | 1.51 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.86 x |
P/E ratio 2023 |
-2.37
x | P/E ratio 2024 * |
-2.46
x | Employees | 255 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.37% |
Latest transcript on MDxHealth SA
1 week | +10.76% | ||
Current month | -4.63% | ||
1 month | -0.80% | ||
3 months | -36.34% | ||
6 months | -1.20% | ||
Current year | -37.31% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.47 | 0.00% | 26,967 |
24-04-25 | 2.47 | -0.80% | 40,509 |
24-04-24 | 2.49 | +1.63% | 37,177 |
24-04-23 | 2.45 | +4.26% | 33,713 |
24-04-22 | 2.35 | +5.38% | 45,573 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.31% | 67.4M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MDXH Stock